1. Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biol Psychiatry. 2011. 69:424–431.
Article
2. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003. 26:507–513.
Article
3. Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions fromcomputational models of striatal-cortical dysfunction. Biol Psychiatry. 2007. 62:756–764.
Article
4. Prentice KJ, Gold JM, Buchanan RW. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophr Res. 2008. 106:81–87.
Article
5. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003. 160:13–23.
Article
6. Frank MJ. Schizophrenia: a computational reinforcement learning perspective. Schizophr Bull. 2008. 34:1008–1011.
Article
7. Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007. 93:253–260.
Article
8. Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull. 2008. 34:835–847.
Article
9. Wächter T, Lungu OV, Liu T, Willingham DT, Ashe J. Differential effect of reward and punishment on procedural learning. J Neurosci. 2009. 29:436–443.
Article
10. Association AP. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 2000. Washington: American Psychiatric Publishing.
11. Raven J, Court J, Raven J. Raven-Matrizen-test standard progressive matrices. 1988. Weinheim: Test Gesellschaft.
12. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976. 85:374.
Article
13. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988. 54:1063.
Article
14. Min BB, Oh HS, Lee JY. Temperament and Character Inventory(TCI) Manual. 2007. Seoul: Maumsarang.
15. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and Validity of the Korean Version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc. 2001. 40:1090–1105.
16. van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res. 2006. 85:280–287.
Article
17. Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998. 24:413–424.
Article
18. Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res. 2007. 93:296–303.
Article
19. Lee Y, Kim YT, Seo E, Park O, Jeong SH, Kim SH, et al. Dissociation of emotional decision-making from cognitive decision-making in chronic schizophrenia. Psychiatry Res. 2007. 152:113–120.
Article
20. Danion JM, Gokalsing E, Robert P, Massin-Krauss M, Bacon E. Defective relationship between subjective experience and behavior in schizophrenia. Am J Psychiatry. 2001. 158:2064–2066.
Article
21. Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. 2004. 5:483–494.
Article
22. Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol (Copenh). 1982. 51:321–329.
Article
23. Borison R. The role of cognition in the risk-benefit and safety analysis of antipsychotic medication. Acta Psychiatr Scand Suppl. 1996. 94:5–11.
Article